You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 12, 2026

Drug Price Trends for RENO CAPS SOFTGEL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for RENO CAPS SOFTGEL

Best Wholesale Price for RENO CAPS SOFTGEL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
RENO CAPS SOFTGEL Nnodum Pharmaceuticals Corporation 63044-0622-01 100 11.06 0.11060 EACH 2024-01-01 - 2028-12-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

RENO CAPS SOFTGEL Market Analysis and Financial Projection

Last updated: February 16, 2026

What Is RENO CAPS SOFTGEL?

RENO CAPS SOFTGEL is a dietary supplement marketed primarily for kidney health. Its formulation typically includes ingredients such as vitamins, minerals, and herbal extracts designed to support renal function. The product is sold over-the-counter (OTC) in various regions, with packaging and formulation variations depending on local regulatory requirements.

What is the Current Market Size for RENO CAPS SOFTGEL?

The specific market size for RENO CAPS SOFTGEL is difficult to determine due to its classification as a dietary supplement, which is not regulated as a pharmaceutical. Globally, the dietary supplement market was valued at approximately $150 billion in 2022, with a compound annual growth rate (CAGR) of 8% from 2020 to 2027 [1].

Within this market, kidney health supplements occupy an estimated 4-6% share. Based on that, the kidney health segment alone could be valued at roughly $6-9 billion globally. RENO CAPS SOFTGEL, as a brand within this category, likely holds an incremental share, often estimated at less than 1% of the total kidney supplement segment.

Regional markets exhibit notable differences:

  • North America: Largest market, driven by high awareness, with an estimated 40% of global sales in dietary kidney health supplements.
  • Europe: Accounts for approximately 25% of sales, with growing demand.
  • Asia-Pacific: Fastest growth, with an estimated CAGR of 10%, driven by increasing health awareness and rising prevalence of chronic kidney disease (CKD).

What Is the Competitive Landscape?

The kidney health supplement market includes multiple branded products and private-label offerings. Key competitors include:

  • CKD-specific brands: Renadyl (Rebifol), RenNu, and other brands with established distribution.
  • General kidney health supplements: Now Foods Kidney Support, Solgar Potassium-Phosphorus formulas.

Market entry is relatively accessible due to low regulatory barriers for OTC dietary supplements but challenges arise from:

  • Brand differentiation based on formulation.
  • Consumer trust and influencer marketing.
  • Distribution channels: health stores, online retail, and pharmacies.

RENO CAPS SOFTGEL’s positioning relies heavily on its formulation efficacy, consumer perception, and pricing strategies.

What Are Pricing Trends and Projections for RENO CAPS SOFTGEL?

Retail prices for kidney health supplements generally range from $15 to $35 per bottle, with per-unit costs around $0.50 to $2, depending on bottle size and formulation.

Current Pricing

For RENO CAPS SOFTGEL:

  • Average retail price: approximately $20 for a 60-capsule bottle.
  • Cost per capsule: approximately $0.33.
  • Pricing strategy: positioned as a mid-tier supplement, balancing quality with affordability.

Historical Pricing Trends

Over the past five years, prices for kidney health supplements have remained relatively stable, with minor fluctuations due to raw material costs and marketing expenses.

Projected Price Movements

Given the industry trends:

  • Slight price increases (2-3%) expected annually due to inflation and rising raw material costs.
  • Premium formulations or organic certifications could command higher prices—up to $30-$40, especially in markets emphasizing quality and natural ingredients.

Market Penetration and Price Sensitivity

Consumer sensitivity to price varies:

  • In North America, consumers demonstrate willingness to pay higher prices for perceived quality.
  • In emerging markets like Asia-Pacific, price remains a key factor, favoring lower-cost offerings.

What Are the Key Drivers and Barriers Affecting Market and Price Projections?

Drivers:

  • Increasing prevalence of CKD and related health awareness.
  • Growing demand for OTC supplements for preventive health.
  • Expansion of online retail channels.

Barriers:

  • Strict regulatory oversight in certain geographies (e.g., European Union, US).
  • Competition from established brands and generics.
  • Consumer skepticism regarding supplement efficacy.

How Do Regulatory Frameworks Impact Market and Price Trends?

Regulatory oversight differs globally:

  • United States: Dietary supplements are regulated under the Dietary Supplement Health and Education Act (DSHEA). No pre-market approval required, but manufacturing practices are monitored.
  • European Union: Receives stricter regulation. Claims must comply with health claim regulations, impacting product marketing and pricing.
  • Asia-Pacific: Varies significantly, with some markets requiring registration and local compliance, which can increase development costs and influence final retail prices.

What Are Future Market and Price Outlooks?

The kidney supplement segment is expected to grow at a CAGR of 8-10% through 2030, driven by increasing CKD incidence. As competition intensifies and consumer preferences shift towards natural and organic products, pricing strategies will adapt accordingly.

  • Mid-tier products like RENO CAPS SOFTGEL will face pressure to maintain competitive pricing.
  • Premium offerings could see higher margins if backed by strong efficacy evidence and certifications.

Key Takeaways

  • The global dietary supplement market is valued at over $150 billion, with kidney health products representing a small but growing segment.
  • RENO CAPS SOFTGEL’s current retail price is around $20 per bottle, with modest annual price increases expected.
  • Market growth is driven by rising CKD prevalence and health awareness.
  • Competition is intense, with key differentiation based on formulation and brand trust.
  • Regulatory environments influence market access and pricing strategies across regions.

FAQs

1. What is the target demographic for RENO CAPS SOFTGEL?
Adults concerned about kidney health, often middle-aged and senior consumers, with higher prevalence among those with existing health conditions or at risk for CKD.

2. How significant is online retail for kidney supplements like RENO CAPS?
Online sales constitute approximately 30-40% of the market, a trend expected to increase as consumers seek convenience and detailed product information.

3. What raw material costs impact pricing?
Ingredients like herbal extracts and vitamins are subject to supply fluctuations, affecting production costs and retail pricing.

4. Can regulatory changes impact the market?
Yes, stricter regulations or new health claims regulations can alter marketing approaches, product formulation, and pricing structures.

5. How does consumer perception influence pricing strategies?
Perceptions of efficacy, quality certifications, and organic labeling enable higher price points and brand differentiation.


References

[1] Grand View Research. (2022). Dietary Supplements Market Size, Share & Trends Analysis Report.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.